Inhibition of a cellular stress response may be a therapeutic target for ALS type 8 related to mutations in the VAPB gene, a ...

Thanks to a gift from her husband with ALS, columnist Kristin Neva takes a journey through joy and sorrow in years of ...

Guest writer Anita Newton discusses the difficult decisions that must be made as ALS progresses. None of them are easy.

Exposure to rhodamine B (RhB), a toxic fluorescent dye, causes neurodegeneration, symptoms that resemble ALS, and molecular ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Far-field potentials (FFPs), nerve signals that can be measured on the skin, show promise as diagnostic and prognostic ...

Columnist Dagmar Munn feels as if she's finding her voice again as she picks up her speech exercises, and then some.

Like any mom, Luz was shocked when her 19-year-old daughter, Emma, was diagnosed with ALS. Discover how they learned to face ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...

AB Science's new Phase 3 trial of masitinib for ALS has been cleared to launch in certain European countries, as well as in ...